世界のペプチドワクチン（Peptide Vaccine）市場...市場調査レポートについてご紹介

1. Introduction to Peptide Vaccine

2. Mechanism of Peptide Vaccine

3. Global Peptide Vaccine Market Overview
3.1 Current Market Scenario
3.2 Peptide Vaccine Clinical Pipeline Overview

4. Global Peptide Vaccine Market Dynamics
4.1 Market Drivers
4.2 Challenges

5. Global Peptide Vaccine Market Future Prospects

6. Global Peptide Vaccine Pipeline by Phase, Indication, Company & Country
6.1 Research
6.2 Preclinical
6.3 Clinical
6.4 Phase-I
6.5 Phase-I/II
6.6 Phase-II
6.7 Phase-II/III
6.8 Phase-III

7. Discontinued & No Development Reported in Peptide Vaccine Clinical Pipeline
7.1 No Development Reported
7.2 Discontinued

8. Competitive Landscape
8.1 Apitope Technology
8.2 BiondVax Pharmaceuticals Ltd
8.3 Circassia
8.4 Eli Lily
8.5 Galena Biopharmaceuticals
8.6 GlaxoSmithKline
8.7 Hyperion Therapeutics
8.8 ImmunoCellular Therapeutics
8.9 Merck
8.10 OncoTherapy Science

Figure 1-1: Different Types of Vaccines
Figure 1-2: Criteria for Ideal Peptide Vaccine
Figure 1-3: Peptide Vaccines Delivery System
Figure 2-1: Mechanism of Peptide Vaccines
Figure 2-2: Mechanism of Live Vaccines
Figure 2-3: Mechanism of Toxoid & Inactivated Vaccine
Figure 2-4: Mode of Action of Peptide Cancer Vaccines
Figure 3-1: Global Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-2: Global Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 3-3: No Development Reported in Global Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-4: No Development Reported in Global Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 3-5: Discontinued Peptide Vaccine Pipeline by Phase (%), 2014
Figure 3-6: Discontinued Peptide Vaccine Pipeline by Phase (Number), 2014
Figure 4-1: Global Peptide Vaccine Market Drivers
Figure 4-2: Global Peptide Vaccine Market Challenges